Oculis Holding AG (OCS) Assets (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Assets came in at $311.6 million in Q1 2026, up 37.21% year-on-year from $227.1 million in Q1 2025, and up 5.54% quarter-over-quarter from $295.2 million in Q4 2025.

Oculis Holding AG (OCS) Assets (2021 - 2026) Analysis & Trends

Oculis Holding AG's Assets history runs 6 years deep, the most recent figure standing at $311.6 million for Q1 2026.

  • On a quarterly basis, Assets rose 37.21% year-over-year to $311.6 million in Q1 2026; TTM through Mar 2026 was $311.6 million, a 37.21% increase from a year earlier, with the FY2025 full-year figure at $284.6 million, up 108.03% from the prior year.
  • Assets climbed to $311.6 million in Q1 2026 per OCS's latest filing, from $295.2 million in the prior quarter.
  • Across five years, Assets topped out at $311.6 million in Q1 2026 and bottomed at $38.5 million in Q4 2022.
  • The 5-year median for Assets is $150.0 million (2023), against an average of $175.0 million.
  • Across the five-year window, Assets sank 38.89% in 2022 and soared 235.12% in 2023, its largest moves.
  • Year by year, Assets stood at $38.5 million in 2022, then surged by 235.12% to $128.9 million in 2023, then increased by 6.57% to $137.4 million in 2024, then surged by 114.89% to $295.2 million in 2025, then climbed by 5.54% to $311.6 million in 2026.
  • Per Business Quant, the three latest OCS Assets figures stand at $311.6 million (Q1 2026), $295.2 million (Q4 2025), and $209.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 311.58 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 78.88 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 33.89 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 8.55 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 811.27 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.25 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 5.13 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 311.58 Mn
Dec 31, 2025 295.23 Mn
Sep 30, 2025 209.81 Mn
Jun 30, 2025 219.38 Mn
Mar 31, 2025 227.09 Mn
Dec 31, 2024 137.39 Mn
Sep 30, 2024 144.98 Mn
Jun 30, 2024 153.41 Mn
Mar 31, 2024 113.09 Mn
Dec 31, 2023 128.92 Mn
Sep 30, 2023 145.98 Mn
Jun 30, 2023 149.97 Mn
Dec 31, 2022 38.47 Mn
Dec 31, 2021 62.95 Mn